Loading...
Back to narrative

OLPX: Stable Margins Will Support Future Share Recovery Despite Competitive Headwinds

Update shared on 08 Dec 2025

n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-35.3%
7D
5.7%

Analysts have trimmed their price target on Olaplex Holdings to $1.40 from $1.75, citing a more cautious outlook on the company despite relatively stable long term growth and profitability assumptions.

Analyst Commentary

Analysts are reassessing Olaplex Holdings in light of the reduced price target, weighing the company’s long term growth prospects against execution risks and a still challenging competitive backdrop.

Bullish Takeaways

  • Bullish analysts note that an Equal Weight rating implies the current valuation already reflects much of the recent operational challenges, which they believe limits further downside in the base case.
  • There is recognition that core brand awareness and a differentiated product portfolio continue to support a long duration revenue stream, which can underpin stable, if modest, growth.
  • Some see incremental upside if management can stabilize salon and retail channel trends, and they argue that even small improvements in volume or pricing could have a leveraged impact on earnings.
  • Bullish analysts highlight that disciplined cost control and margin preservation efforts give the company flexibility to navigate a slower demand environment without a dramatic hit to profitability.

Bearish Takeaways

  • Bearish analysts view the lowered price target as evidence that execution risk remains elevated, particularly around reaccelerating top line growth in a crowded haircare category.
  • Concerns persist that competitive pressures and shifting consumer preferences could cap market share gains, which may limit the multiple investors are willing to pay for future earnings.
  • Some remain skeptical that management can quickly restore prior growth trajectories, and they suggest that consensus expectations may still be too optimistic relative to current sell through trends.
  • Bearish analysts argue that, without clear evidence of sustainable reacceleration, the stock may struggle to re rate meaningfully, which could keep valuation closer to a no growth scenario for now.

Valuation Changes

  • Fair value estimate remained unchanged at $1.89 per share, indicating no shift in the intrinsic value assessment despite the lower target price.
  • The discount rate decreased slightly from 8.43 percent to about 8.34 percent, reflecting a modest reduction in perceived risk or required return.
  • Revenue growth was effectively unchanged at roughly 2.93 percent, signaling stable expectations for top-line expansion.
  • The net profit margin was essentially flat at about 11.01 percent, suggesting no material revision to long-term profitability assumptions.
  • The future P/E edged down marginally from about 32.36x to 32.28x, pointing to a slightly lower valuation multiple applied to forward earnings.

Have other thoughts on Olaplex Holdings?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.